These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 187956)

  • 21. Alterations in opiate receptor function after chronic ethanol exposure.
    Hoffman PL; Urwyler S; Tabakoff B
    J Pharmacol Exp Ther; 1982 Jul; 222(1):182-9. PubMed ID: 6283066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
    Lubetzki C; Chesselet MF; Glowinski J
    J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Kinetics of 14C-dopamine in isolated rat striatal tissue under the influence of morphine.
    Kuschinsky K; Celsen B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R54. PubMed ID: 4276596
    [No Abstract]   [Full Text] [Related]  

  • 24. Electroconvulsive shock blocks the opioid-mediated inhibition of dopamine release in rat striatal slices.
    Passarelli F; Carmenini E; Calò L; Orzi F; Pontieri FE
    J Neural Transm (Vienna); 1997; 104(8-9):805-10. PubMed ID: 9451713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
    Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
    Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release.
    Mulder AH; Wardeh G; Hogenboom F; Frankhuyzen AL
    Nature; 1984 Mar 15-21; 308(5956):278-80. PubMed ID: 6322011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of etorphine, fentanyl and morphine on noradrenaline and dopamine concentrations in the striatum of rat.
    Teuchmann JK; Kania BF
    Acta Physiol Pol; 1977; 28(2):107-12. PubMed ID: 868528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue.
    Booth RG; Baldessarini RJ
    Brain Res; 1991 Aug; 557(1-2):349-52. PubMed ID: 1684130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin facilitates dopamine release in vitro from rat striatal slices.
    de Quidt ME; Emson PC
    Brain Res; 1983 Sep; 274(2):376-80. PubMed ID: 6626967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L; Kaakkola S
    Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation.
    Xu K; Dluzen DE
    Exp Neurol; 2000 Dec; 166(2):450-7. PubMed ID: 11085910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
    Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mazindol, nomifensine and desmethylimipramine inhibit potassium-induced release of dopamine: effect of stimulus strength.
    Dembiec-Cohen D
    J Neural Transm (Vienna); 1998; 105(6-7):735-47. PubMed ID: 9826115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actions of narcotics on brain dopamine metabolism and their relevance for "psychomotor" effects.
    Kuschinsky K
    Arzneimittelforschung; 1976 Apr; 26(4):563-7. PubMed ID: 8059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MPP+ enhances potassium-evoked striatal dopamine release through a omega-conotoxin-insensitive, tetrodotoxin- and nimodipine-sensitive calcium-dependent mechanism.
    Chiueh CC; Huang SJ
    Ann N Y Acad Sci; 1991; 635():393-6. PubMed ID: 1741592
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine.
    Vaccari A; Del Zompo M; Melis F; Gessa GL; Rossetti ZL
    Br J Pharmacol; 1991 Nov; 104(3):573-4. PubMed ID: 1797320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.
    Zazpe A; Artaiz I; Del Río J
    Br J Pharmacol; 1994 Nov; 113(3):968-72. PubMed ID: 7858893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromogranin A inhibits dopamine release from rat striatal slices.
    Gibson CJ; Munoz DG
    J Neural Transm (Vienna); 1998; 105(10-12):1083-9. PubMed ID: 9928879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of pH on beta-endorphin and morphine inhibition of calcium transients in dorsal root ganglion neurons.
    Vetter I; Kapitzke D; Hermanussen S; Monteith GR; Cabot PJ
    J Pain; 2006 Jul; 7(7):488-99. PubMed ID: 16814688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
    Johnson MA; Rajan V; Miller CE; Wightman RM
    J Neurochem; 2006 May; 97(3):737-46. PubMed ID: 16573654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.